z-logo
Premium
Antiplatelet therapy as a modulator of stroke aetiology: a meta‐analysis
Author(s) -
Rajkumar Christopher A.,
Floyd Christopher N.,
Ferro Albert
Publication year - 2015
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.12630
Subject(s) - stroke (engine) , medicine , meta analysis , pharmacology , mechanical engineering , engineering
Aims Antiplatelet therapy reduces the incidence of ischaemic stroke. Platelet‐mediated thrombosis contributes variably to the major subtypes of stroke as defined by the TOAST criteria: large artery atherosclerosis (LAA), cardioembolic (CE) and small vessel occlusion (SVO). The effect of antiplatelet therapy on the incidence of each subtype is unknown and is the subject of this meta‐analysis. Methods Electronic databases were searched for articles comparing the effect of antiplatelet therapy on the incidence of stroke according to aetiological subtype. Studies containing subjects prescribed anticoagulant therapy or solely investigating subjects with atrial fibrillation were excluded. Pooled odds ratios (ORs) were calculated using a fixed effects model. Results Nine studies were included ( n  = 5739). In patients who had an ischaemic stroke, pre‐event antiplatelet therapy was associated with significantly decreased incidence of LAA (OR 0.88, 95% CI 0.79, 0.99; P  = 0.026), increased incidence of CE (OR 1.23, 95% CI 1.08, 1.41; P  = 0.002) and no effect on SVO (OR 0.99, 95% CI 0.88, 1.11; P  = 0.806). Concordant non‐significant trends were observed in primary prevention populations ( n  = 751): LAA (OR 0.81, 95% CI 0.57, 1.15; P  = 0.240), CE (OR 1.29, 95% CI 0.89, 1.87; P  = 0.179) and SVO (OR 0.99, 95% CI 0.73, 1.36; P  = 0.970). Subgroup analysis of aspirin monotherapy ( n  = 3786) demonstrated a significant reduction in LAA (OR 0.87, 95% CI 0.76, 1.00; P  = 0.046), but non‐significant effects on the incidence of CE (OR 1.17, 95% CI 0.99, 1.39; P  = 0.068) and SVO (OR 1.04, 95% CI 0.91, 1.20; P  = 0.570). Probability of publication bias was low ( P  > 0.05). Conclusions Antiplatelet therapy preferentially reduces the incidence of LAA stroke compared with CE and SVO subtypes.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here